Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer some Medicare coverage

Trump unveils deals to lower prices of weight loss drugs

Weight loss drug brands Ozempic, Wegovy and Mounjaro have risen sharply in popularity in the US, but they are still considered unaffordable.

MAHA skeptical of Trump plan to curb obesity with cheap Ozempic

Advocates of the Make America Healthy Again agenda have expressed skepticism over President Donald Trump’s agreement with pharmaceutical companies to lower prices and expand access to blockbuster anti-obesity and diabetes medications.  Following Trump’s Oval Office announcement Thursday about drastically lowering costs for Ozempic and other GLP-1 drugs, MAHA leaders told the Washington Examiner that they would prefer to see an elevation of holis…

President Trump Announces Significant Pharmaceutical Deal to Lower Drug Prices, and Answer Media Questions

President Trump made an announcement today in the oval office highlighting two Rx companies, Eli Lilly and Company and Novo Nordisk, to dramatically reduce the prices Americans pay for some of the world’s most popular drugs. [Fact Sheet Here] Following the drug company announcement President Trump took questions from the media.  The press Q&A is […] The post President Trump Announces Significant Pharmaceutical Deal to Lower Drug Prices, and Answ…

TrumpRx: Trump Scores Significantly Lower Prices For Popular Weight Loss Drugs - Real News Now

President Donald Trump announced a sweeping deal on Thursday to slash prices for some of the country’s most sought-after weight loss and diabetes medications, marking a major win for Americans struggling with high out-of-pocket drug costs. Under the new agreements, pharmaceutical giants Eli Lilly and Novo Nordisk will dramatically reduce prices on GLP-1 drugs, including Zepbound, Wegovy, and Ozempic. These medications, widely used for weight los…

Trump unveils deals to lower costs of some weight-loss drugs

US President Donald Trump announced deals Thursday with pharmaceutical giants Eli Lilly and Novo Nordisk to lower the prices of some popular weight-loss drugs, in exchange for relief from threatened tariffs.

Trump Announces Major Deal with Eli Lilly and Novo Nordisk to Slash Cost of GLP-1 Medications for Diabetes and Obesity - RFK Jr. Says the American Public will Lose 125 MILLION LBS by Next Year

President Trump on Thursday announced another deal to cut pharmaceutical costs for Americans with most favored nation (MFN) pricing on popular drugs for diabetes, heart disease, and weight loss, and other conditions.